MiR-217 Regulates SIRT1 Expression and Promotes Inflammatory and Apoptotic Responses in Osteoarthritis

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• MicroRNA-217 (miR-217) upregulation is implicated in age-related diseases.
• Osteoarthritis (OA) is a prevalent age-related degenerative joint disease.

Purpose of the Study:

• To investigate the role of miR-217-5p in regulating sirtuin 1 (SIRT1) in human OA chondrocytes.
• To elucidate the molecular mechanisms underlying miR-217-5p's contribution to OA pathogenesis.

Main Methods:

• Bioinformatic analyses identified SIRT1 as a predicted target of miR-217.
• miR-217-5p expression was quantified in normal and OA chondrocytes.
• OA chondrocytes were treated with miR-217 mimics/inhibitors and/or siRNA against SIRT1 (siSIRT1).
• Expression levels of SIRT1, NF-κBp65 and p53 acetylation, inflammatory markers, apoptotic markers, and matrix regulators were assessed.

Main Results:

• miR-217-5p was significantly upregulated in OA chondrocytes.
• SIRT1 was confirmed as a direct target of miR-217-5p.
• miR-217 inhibition increased COL2A1 and ACAN expression while decreasing pro-inflammatory and pro-apoptotic markers.
• siSIRT1 treatment reversed the protective effects of miR-217 inhibition.

Conclusions:

• miR-217-5p contributes to OA pathogenesis by downregulating SIRT1 expression.
• Targeting miR-217-5p may represent a potential therapeutic approach for osteoarthritis.